← All companies

LNTH Lantheus Holdings, Inc

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · $6.5B market cap · updated 2026-10-07
Market price
$99.95
Avg intrinsic value
$64.97
Margin of safety
-35.0%

Three independent discounted-cash-flow-style models value Lantheus Holdings, Inc every trading day. 0 of 3 currently price LNTH above its market price.

Model estimates

Free Cash Flow model$65.21
Excess Profit model$80.75
Residual Earnings model$48.95
Dividend Discount model—

Quality snapshot

Piotroski F-Score5 / 9
Return on invested capital+13.0%
Net debt / EBITDA1.4×
Gross margin+61.1%
Revenue CAGR+18.1%
Cash conversion1.7×
Dividend yield—
Buyback yield+2.5%

Run your own numbers

These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.

Open LNTH in StockKitty

Same sector